Status:
TERMINATED
Probiotics Supplementation and Intestinal Microbiome in Neonates With Gastrointestinal Surgery
Lead Sponsor:
University of Calgary
Conditions:
Probiotics
Infant, Newborn
Eligibility:
All Genders
Phase:
NA
Brief Summary
Congenital defects of the gastrointestinal tract commonly require surgical intervention in the neonatal period. Intestinal surgery during this critical period of microbiome acquisition results in aber...
Detailed Description
Research Objectives/Question: The main objective of this study is to determine the impact of probiotics administration on the intestinal microbiome in neonates undergoing gastrointestinal surgery. P...
Eligibility Criteria
Inclusion
- Infants born between 23 - 41 weeks of gestation
- Required gastrointestinal surgery (including spontaneous intestinal perforation, bowel atresia, mechanical bowel obstruction, volvulus, gastroschisis)
- Ready to start enteral feeding
Exclusion
- Infants with major congenital anomalies excluding gastrointestinal tract
- Palliative care patients
- 4\. Septic babies with positive blood, CSF or urine culture
Key Trial Info
Start Date :
December 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03266315
Start Date
December 3 2022
End Date
July 15 2024
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T3M1M4